ReproCELL: Change report (exemption share certificates, etc.)
ReproCELL: Announcement regarding the large exercise of the 16th subscription rights (with exercise price adjustment clause and exercise permission clause).
ReproCELL: Announcement regarding the large exercise of the 16th subscription rights (with exercise price adjustment clause and exercise permission clause).
ReproCELL: Announcements of individual stocks regarding the start of providing regenerative medical grade iPS exosomes with JTB Co., Ltd.
ReproCELL: Corporate Governance Report as of July 5, 2024.
ReproCELL: Announcements of individual stocks regarding exercise permission of the 16th subscription rights (with exercise price adjustment clause and exercise permission clause) by third-party allocation.
ReproCELL: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
ReproCELL: Announcements of individual stocks regarding the decision to grant subsidies to the subsidiary (REPROCELL USA Inc.).
ReproCELL: Announcements of individual stocks regarding the monthly exercise status of the 16th subscription rights (with exercise price adjustment and exercise permission clauses).
ReproCELL: Matters related to business plans and growth potential.
ReproCELL: Announcements of individual stocks regarding the decision to grant subsidies to the subsidiary (REPROCELL USA Inc.).
ReproCELL: Articles of Incorporation: June 24, 2024
ReproCELL: Interim report
ReproCELL: Internal Control Report - 22nd Term (2023/04/01 - 2024/03/31)
ReproCELL: Confirmation letter
ReproCELL: Securities Report - 22nd Fiscal Year (2023/04/01 - 2024/03/31)
ReproCELL: Announcements of individual stocks related to personnel changes.
ReproCELL: Notice regarding the monthly exercise status of the 16th Stock Acquisition Rights (with exercise price amendment clauses and exercise permission clauses)
ReproCELL: Notice of Convocation of the 22nd Annual General Meeting of Shareholders
ReproCELL: Notice Concerning Decrease in Capital Reserve Amount and Disposal of Surplus Funds
No Data